FDA Inspection 843004 — Innovative Transfusion Medicine, Inc.

Innovative Transfusion Medicine, Inc. — FEI 3000207042

The FDA completed an inspection of Innovative Transfusion Medicine, Inc. on August 2, 2013 in Miami Lakes, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 2, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Miami Lakes, FL (United States)

Citations

IDCFRDescription
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
924321 CFR 630.40(a)Notification
9821 CFR 606.100(c)Thorough investigations